Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

NCT00525525

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

NCT00024570

Conditions: Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +15 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

Emory University Atlanta, Georgia, United States

The Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

NCT01186601

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +31 more
Locations: Stanford, California, United States

View Trial Details

Completed

High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes

NCT00463892

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Redwood Regional Medical Group Sebastopol, California, United States

View Trial Details

Completed

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

NCT01247623

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Oslo University Hospital Oslo, Postbox 4953, Norway

View Trial Details

Completed

Sorafenib in Newly Diagnosed High Grade Glioma

NCT00884416

Conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +12 more
Locations: Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, Canton of Geneva, Switzerland

View Trial Details

Completed

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

NCT00689221

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States

Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany

View Trial Details

Completed

Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

NCT00324155

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Pacific Cancer Medical Center Anaheim, California, United States

Wilshire Oncology Medical Group Inc La Verne, California, United States

The Angeles Clinic And Research Institute Los Angeles, California, United States

Comprehensive Cancer Center Palm Springs, California, United States

View all 127 locations

View Trial Details

Completed

A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma

NCT00492297

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Bordeaux, France

Lyon, France

Toulouse, France

Villejuif, France

View Trial Details

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

NCT00470379

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions